BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36844178)

  • 1. Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel.
    Pagano L; Zinzani PL; Pileri S; Quaglino P; Cuglievan B; Berti E; Pemmaraju N; Onida F; Willemze R; Orfao A; Barosi G
    Hemasphere; 2023 Mar; 7(3):e841. PubMed ID: 36844178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
    Quaglino P; Pimpinelli N; Zinzani PL; Paulli M; Pileri S; Berti E; Cerroni L; Guitart J; Kim YH; Rupoli S; Santucci M; Simontacchi G; Vermeer M; Hoppe R; Pro B; Swerdlow SH; Barosi G
    Hematol Oncol; 2024 Jan; 42(1):e3215. PubMed ID: 37649350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.
    Zinzani PL; Paulli M; Arcaini L; Della Torre E; Ferrero S; Figuera A; Frigeri F; Martelli M; Sabattini E; Scarpa R; Barosi G
    Hemasphere; 2023 Jun; 7(6):e891. PubMed ID: 37234822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
    Wang S; Wang X; Liu M; Bai O
    Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic plasmacytoid dendritic cell neoplasm: A case report.
    Wang W; Li W; Jia JJ; Zheng Y; Wang H; Gao XM; Dong XY; Tian Q; Jing HL; Wang X; Xiao SX
    Oncol Lett; 2015 Mar; 9(3):1388-1392. PubMed ID: 25663917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang Y; Sokol L
    Cancer Manag Res; 2022; 14():2107-2117. PubMed ID: 35789956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
    Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
    Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
    Kubota S
    Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm presenting with a cutaneous tumor alone as the first symptom of onset: A case report and review of literature.
    Yu G; Wang W; Han Y; Liu J; Pan X; Qu G
    Oncol Lett; 2015 Feb; 9(2):819-821. PubMed ID: 25621057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor.
    Pak DM; Tretiakova MS
    Case Rep Pathol; 2019; 2019():9196167. PubMed ID: 31687245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm in a child: A challenging diagnosis and management.
    Rivas-Calderón MK; Cheirif-Wolosky O; Rosas-Romero ME; Toussaint-Caire S; Duran-Mckinster C; González-Pedroza ML; López-Santiago NC; García-Romero MT
    Pediatr Dermatol; 2021 Jan; 38(1):260-262. PubMed ID: 33275310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy.
    Narli Ozdemir Z; Cengiz Seval G; Sahin U; Uslu A; Gunduz M; Civriz Bozdag S; Toprak SK; Kurt Yuksel M; Topcuoglu P; Kuzu I; Ozcan M; Gurman G; Ilhan O
    Indian J Hematol Blood Transfus; 2021 Jan; 37(1):67-75. PubMed ID: 33707837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic plasmacytoid dendritic cell neoplasm with skin and bone marrow involvement: Report of three cases.
    Guo JH; Zhang HW; Wang L; Bai W; Wang JF
    World J Clin Cases; 2021 Nov; 9(33):10293-10299. PubMed ID: 34904102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms.
    Owczarczyk-Saczonek A; Sokołowska-Wojdyło M; Olszewska B; Malek M; Znajewska-Pander A; Kowalczyk A; Biernat W; Poniatowska-Broniek G; Knopińska-Posłuszny W; Kozielec Z; Nowicki R; Placek W
    Postepy Dermatol Alergol; 2018 Apr; 35(2):128-138. PubMed ID: 29760611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
    Adimora IJ; Wilson NR; Pemmaraju N
    Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.